![](https://zephyrnet.com/wp-content/uploads/2022/11/alloy-therapeutics-in-business-wire-alloy-therapeutics-and-normunity-sign-multi-program-antibody-discovery-collaboration-in-immuno-oncology.png)
BOSTON–(BUSINESS WIRE)–Alloy Therapeutics, a biotechnology ecosystem company, announced an antibody discovery collaboration spanning multiple precision immuno-oncology programs for Normunity, a biotech company that recently announced its $65 million Series A financing. The collaboration will support the advancement of Normunity’s immune normalizers, antibody therapies designed to target novel mechanisms that free the body’s normal immunity to fight cancer, which are conceived through a unique biotech-academic collaboration with a renowned immuno-oncology university research lab.
Read more here.
- Coinsmart. Europe’s Best Bitcoin and Crypto Exchange.Click Here
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://blog.ourcrowd.com/alloy-therapeutics-and-normunity-sign-multi-program-antibody-discovery-collaboration-in-immuno-oncology/